FAM
TMO icon

Fulcrum Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Fulcrum Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,747
Closed -$2.99M – 356
2025
Q1 		$2.99M Buy
+7,747
New +$4.2M 0.58% 47

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fulcrum Asset Management's TMO Position: Q2 2026 in Review

Fulcrum Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 76% in Q2 2026, selling an estimated $2.9M and leaving 1,864 shares worth $944K. The position accounts for 0.09% of the portfolio, ranked #221.

Fulcrum Asset Management first reported a position in TMO in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.56M in Q4 2025. 2,632 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Fulcrum Asset Management held 1,864 shares of Thermo Fisher Scientific worth $944K as of Q2 2026.
  • Fulcrum Asset Management sold 6,043 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.9M.
  • Thermo Fisher Scientific made up 0.09% of Fulcrum Asset Management's portfolio in Q2 2026, its #221 holding.
  • Fulcrum Asset Management first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 5 quarters since.
  • Fulcrum Asset Management's Thermo Fisher Scientific position peaked at $4.56M in Q4 2025.
  • 2,632 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Fulcrum Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.